Prevalence and treatment of Gram-positive infections in internal medicine departments of Spanish hospitals: IGP Study;Prevalencia y tratamiento de las infecciones por Grampositivos en los servicios de medicina interna de hospitales Españoles: Estudio IGP

Revista Espanola de Quimioterapia

Volumn 16, Issue 4, 2003, Pages 428-435

  Gonzalez Romo F ^a   Rubio, M ^b   Betriu, C ^a   Picazo, J J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Comparative study; Gram positive infections; Prevalence; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD VESSEL CATHETERIZATION; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG USE; FEMALE; GRAM POSITIVE BACTERIUM; HEART DISEASE; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILIZATION; INCIDENCE; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; SPAIN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URINE CATHETER;

FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; PREVALENCE; SPAIN;

EID: 0842321946     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Grupo de trabajo EPINE. Evolución de la prevalencia de las infecciones nosocomiales en los hospitales españoles (Proyecto EPINE 1990-1999). Vaqué, J., Roselló, J. (Eds.). Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, Madrid 2001.
2. Weinstein, M.P., Towns, M.L., Quartey, S.M. y cols. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
3. Schaberg, D.R., Culver, D.H., Gaynes, R.P. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91: 72S-75S.
4. Cockerill, F.R., Hughes, J.G., Vetter, E.A. y cols. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: Trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 1997; 24: 403-418.
5. EORTC. International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. Eur J Cancer 1990; 26: 569-574.
6. Rubio, M., Palau, L., Vivas, J.R. y cols. Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994; 15: 101-104.
7. González Barca, E., Fernández Sevilla, A., Carratalá, J., Granena, A., Gudiol, F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15: 291-296.
8. Edmond, M.B., Wallace, S.E., McClish, D.K., Pfaller, M.A., Jones, R.N., Wenzel, R.P. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 1999; 29: 239-244.
9. Garner, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C., Hughes, J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
10. McCabe, W.R., Jackson, G.G. Gram-negative bacteremia. Arch Intern Med 1962; 110: 847-855.
11. Martínez, J.A., Mensa, J. Infección nosocomial. Med Clin (Barc) 1999; 113: 611-613.
12. Ena, J., Dick, R.W., Jones, R.N., Wenzel, R.P. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA 1993; 269: 598-602.
13. Richards, M.J., Edwards, J.R., Culver, D.H., Gaynes, R.P. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27: 887-892.
14. Jarvis, W.R. Epidemiology, appropriateness, and cost of vancomycin use. Clin Infect Dis 1998; 26: 1200-1203.
15. Evans, M.E., Kortas, K.J. Vancomycin use in an university medical center: Comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996; 17: 356-359.
16. Deeks, S.G., Smith, M., Holodniy, M., Kahn, J.O. HIV-I protease inhibitors. A review for clinicians. JAMA 1997; 277: 145-153.
17. Tumbarello, M., Tacconelli, E., de Gaetano Donati, K., Cauda, R. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 208-209.
18. Tumbarello, M., Tacconelli, E., Donati, K.G. y cols. HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145-151.
19. Mouton, Y., Alfandari, S., Valette, M. y cols. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997; 11: F101-105.
20. Tacconelli, E., Tumbarello, M., de Gaetano, K., Cauda, R., Ortona, L. Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals. Clin Infect Dis 1998; 27: 901-902.
21. Paul, S., Gilbert, H.M., Ziecheck, W., Jacobs, J., Sepkowitz, K.A. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS 1999; 13: 415-418.
22. Raad, I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-898.
23. Mermel, L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402.
24. Pfaller, M.A., Jones, R.N., Doern, G.V., Kugler, K. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-1770.
25. Crowe, M., Ispahani, P., Humphreys, H., Kelley, T., Winter, R. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 1998; 17: 377-384.
26. Ezpeleta, C. Bacteriemias intrahospitalarias. Rev Clin Esp 1997; 197 (Suppl. 5): 15-20.
27. Banerjee, S.N., Emori, T.G., Culver, D.H. y cols. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 86S-89S.
28. Navas, E. Bacteriemia asociada a catéter. Rev Clin Esp 1997; 197 (Suppl. 5): 41-44.
29. Levine, D.P., Brown, P.D. Infections in injections drug users. En: Mandel, G.L. Bennet, J.E., Dolin, R. (Eds.). Principles and Practice of Infectious Diseases. Churchill-Livingstone, Philadelphia, PA 2000; 3112-3125.
30. Haverkos, H.W., Lange, W.R. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990; 161: 894-902.
31. McGowan, J.E. The impact of changing pathogens of serious infections in hospitalized patients. Clin Infect Dis 2000; 31 (Suppl. 4): S124-130.
32. Akram, J., Glatt, A.E. True community-acquired methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19: 106-107.
33. Redd, S.C., Rutherford, G.W.D., Sande, M.A. y cols. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162: 1012-1017.